These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18240972)

  • 61. Bone Morphogenetic Proteins and myostatin pathways: key mediator of human sarcopenia.
    Scimeca M; Piccirilli E; Mastrangeli F; Rao C; Feola M; Orlandi A; Gasbarra E; Bonanno E; Tarantino U
    J Transl Med; 2017 Feb; 15(1):34. PubMed ID: 28202082
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Restorative effects of (+)-epicatechin in a rodent model of aging induced muscle atrophy: underlying mechanisms.
    Ramirez-Sanchez I; Navarrete-Yañez V; Ramirez L; Galera L; Mendez-Bolaina E; Najera V; Ceballos G; Villarreal F
    Food Funct; 2024 Apr; 15(7):3669-3679. PubMed ID: 38487922
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improvement of muscular atrophy by AAV-SaCas9-mediated myostatin gene editing in aged mice.
    Weng S; Gao F; Wang J; Li X; Chu B; Wang J; Yang G
    Cancer Gene Ther; 2020 Dec; 27(12):960-975. PubMed ID: 32398787
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relative Contributions of Myostatin and the GH/IGF-1 Axis in Body Composition and Muscle Strength.
    Lozier NR; Kopchick JJ; de Lacalle S
    Front Physiol; 2018; 9():1418. PubMed ID: 30443216
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease.
    van Langenberg DR; Della Gatta P; Hill B; Zacharewicz E; Gibson PR; Russell AP
    J Crohns Colitis; 2014 Jul; 8(7):626-34. PubMed ID: 24332699
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Myostatin polymorphisms and age-related sarcopenia in the Italian population.
    Corsi AM; Ferrucci L; Gozzini A; Tanini A; Brandi ML
    J Am Geriatr Soc; 2002 Aug; 50(8):1463. PubMed ID: 12165013
    [No Abstract]   [Full Text] [Related]  

  • 67. Changes in myostatin signaling in non-weight-losing cancer patients.
    Aversa Z; Bonetto A; Penna F; Costelli P; Di Rienzo G; Lacitignola A; Baccino FM; Ziparo V; Mercantini P; Rossi Fanelli F; Muscaritoli M
    Ann Surg Oncol; 2012 Apr; 19(4):1350-6. PubMed ID: 21519918
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Preventive Effect of Specific Collagen Peptides against Dexamethasone-Induced Muscle Atrophy in Mice.
    Oh J; Park SH; Kim DS; Choi W; Jang J; Rahmawati L; Jang WY; Lim HK; Hwang JY; Gu GR; Geum JH; Choi SY; Kim JH; Cho JY
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838938
    [TBL] [Abstract][Full Text] [Related]  

  • 69. lncRNA Chronos is an aging-induced inhibitor of muscle hypertrophy.
    Neppl RL; Wu CL; Walsh K
    J Cell Biol; 2017 Nov; 216(11):3497-3507. PubMed ID: 28855249
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Muscle-tendon cross talk during muscle wasting.
    Avey AM; Baar K
    Am J Physiol Cell Physiol; 2021 Sep; 321(3):C559-C568. PubMed ID: 34319830
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exercise training increases anabolic and attenuates catabolic and apoptotic processes in aged skeletal muscle of male rats.
    Ziaaldini MM; Koltai E; Csende Z; Goto S; Boldogh I; Taylor AW; Radak Z
    Exp Gerontol; 2015 Jul; 67():9-14. PubMed ID: 25910622
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Muscle-related traits in cattle: The role of the myostatin gene in the South Devon breed.
    Wiener P; Smith JA; Lewis AM; Woolliams JA; Williams JL
    Genet Sel Evol; 2002; 34(2):221-32. PubMed ID: 12081809
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diabetic sarcopenia: metabolic and molecular appraisal.
    Giha HA; Alamin OAO; Sater MS
    Acta Diabetol; 2022 Aug; 59(8):989-1000. PubMed ID: 35429264
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of serum myostatin in the association between hyperinsulinemia and muscle atrophy in Japanese obese patients.
    Tanaka M; Masuda S; Yamakage H; Inoue T; Ohue-Kitano R; Yokota S; Kusakabe T; Wada H; Sanada K; Ishii K; Hasegawa K; Shimatsu A; Satoh-Asahara N
    Diabetes Res Clin Pract; 2018 Aug; 142():195-202. PubMed ID: 29859272
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction.
    Lee SJ
    J Clin Invest; 2021 May; 131(9):. PubMed ID: 33938454
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort.
    Seibert MJ; Xue QL; Fried LP; Walston JD
    J Am Geriatr Soc; 2001 Aug; 49(8):1093-6. PubMed ID: 11555072
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transcriptional pathways associated with skeletal muscle disuse atrophy in humans.
    Chen YW; Gregory CM; Scarborough MT; Shi R; Walter GA; Vandenborne K
    Physiol Genomics; 2007 Nov; 31(3):510-20. PubMed ID: 17804603
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current understanding of sarcopenia: possible candidates modulating muscle mass.
    Sakuma K; Aoi W; Yamaguchi A
    Pflugers Arch; 2015 Feb; 467(2):213-29. PubMed ID: 24797147
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Myostatin Increases Smad2 Phosphorylation and Atrogin-1 Expression in Chick Embryonic Myotubes.
    Saneyasu T; Honda K; Kamisoyama H
    J Poult Sci; 2019 Jul; 56(3):224-230. PubMed ID: 32055218
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats.
    Pötsch MS; Tschirner A; Palus S; von Haehling S; Doehner W; Beadle J; Coats AJ; Anker SD; Springer J
    J Cachexia Sarcopenia Muscle; 2014 Jun; 5(2):149-58. PubMed ID: 24272787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.